Biljana Nadjsombati
Corporate Officer/Principal bei VIRACTA THERAPEUTICS, INC.
Ursprung des Netzwerks ersten Grades von Biljana Nadjsombati
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 25 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Biljana Nadjsombati
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CVS HEALTH CORPORATION | Drugstore Chains | Corporate Officer/Principal | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
American Medical Association
 American Medical Association Miscellaneous Commercial ServicesCommercial Services American Medical Association engages in promoting the art and science of medicine and the betterment of public health. It offers services to physicians, residents, medical students, and patients. The company was founded by Nathan Smith Davis in 1847 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Medco Health Solutions, Inc.
 Medco Health Solutions, Inc. Medical/Nursing ServicesHealth Services Medco Health Solutions, Inc. retails drugs, pharmaceuticals and other health products through online. The firm provides pharmacy services which are designed for private and public employers, health plans, labor unions government agencies of all sizes and individuals. The company was founded in June 1983 and is headquartered in Franklin Lakes, NJ. | Medical/Nursing Services | Corporate Officer/Principal | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Undergraduate Degree | |
| MORPHOSYS AG | Biotechnology | Corporate Officer/Principal | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
| San Diego State University | College/University | Undergraduate Degree Masters Business Admin | |
| The Johns Hopkins University | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| The University of Alabama | College/University | Masters Business Admin | |
| University of Toronto | College/University | Doctorate Degree | |
| University of California San Diego | College/University | Corporate Officer/Principal Masters Business Admin | |
| University of San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal | |
| MOLECULAR PARTNERS AG | Biotechnology | Chief Tech/Sci/R&D Officer | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| CONTRAFECT CORPORATION | Biotechnology | Chief Executive Officer Director/Board Member | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Università degli Studi di Modena e Reggio Emilia | College/University | Doctorate Degree | |
| Tibotec Pharmaceuticals | Chief Executive Officer | ||
| CANTARGIA AB | Pharmaceuticals: Major | Director/Board Member | |
| COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Chairman | |
| SERA PROGNOSTICS, INC. | Medical/Nursing Services | Director/Board Member | |
| THERAPEUTICSMD, INC. | Pharmaceuticals: Major | Director/Board Member | |
Real Endpoints LLC
 Real Endpoints LLC Data Processing ServicesTechnology Services Real Endpoints LLC provides information and analytics services. It offers information platform to reveal insights about the changing world of product reimbursement. The firm operates its business through Reimbursement Intelligence and RxScorecard. The company was founded by Roger Longman in 2010 and is headquartered in Westport, CT. | Data Processing Services | Corporate Officer/Principal | |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Chief Executive Officer | |
SilverScript Insurance Co.
 SilverScript Insurance Co. Life/Health InsuranceFinance SilverScript Insurance Co. provides health insurance services. It offers Medicare Part D plans for those eligible to enroll in a Medicare prescription drug plan. The company is headquartered in Phoenix, AZ. | Life/Health Insurance | Director/Board Member | |
| REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director/Board Member | |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member Chairman Chief Tech/Sci/R&D Officer Director of Finance/CFO Director/Board Member Director/Board Member | |
| Jane Barlow & Associates LLC | Chief Executive Officer | ||
| ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Pharmaceuticals: Major | Director/Board Member | |
Point Health Tech, Inc.
 Point Health Tech, Inc. Packaged SoftwareTechnology Services Point Health Tech, Inc. engages in the development of healthcare navigation platform and marketplace. The company is headquartered in Austin, TX. | Packaged Software | Director/Board Member | |
| INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Verimmune, Inc.
 Verimmune, Inc. BiotechnologyHealth Technology Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then. | Biotechnology | Director/Board Member | |
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| Silicon Therapeutics, Inc. | Chairman | ||
| The Creighton University School of Medicine | College/University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 35 |
| Schweiz | 4 |
| Israel | 3 |
| Vereinigtes Königreich | 2 |
| Deutschland | 2 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 10 |
| Commercial Services | 3 |
| Health Services | 3 |
| Finance | 3 |
Operativ
| Director/Board Member | 102 |
| Corporate Officer/Principal | 57 |
| Independent Dir/Board Member | 31 |
| President | 23 |
| Chief Executive Officer | 22 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Ivor Royston | 30 |
| Roger Pomerantz | 30 |
| Nicole Onetto | 17 |
| Gur Roshwalb | 17 |
| Michael Huang | 15 |
| Jane Barlow | 15 |
| Barry Simon | 15 |
| Mark Rothera | 14 |
| Thomas Darcy | 13 |
| Lisa Rojkjaer | 12 |
| Stephen Rubino | 10 |
| Flavia Borellini | 9 |
| Sam Murphy | 8 |
| Daniel Chevallard | 7 |
| Shelly Vandertie | 7 |
- Börse
- Insiders
- Biljana Nadjsombati
- Unternehmensverbindungen
